Quality Metrics to foster Continual Quality Improvement
Im Auftrag der European Compliance Academy

16-17 June 2016

Berlin, Germany

Seminar Nr. 15237

Unser Seminarservice

Kosten

Die Veranstaltung hat bereits stattgefunden

Rückfragen unter:
Tel.: 06221 / 84 44 0 E-Mail: info@concept-heidelberg.de

Sprecher

Arnoud Herremans, Lean Kaizen Consultant,The Netherlands
Henny Koch, Qimp Management Systems, The Netherlands
Dorthe Christina Kroun, Bavarian Nordic A/S, Denmark
Dr Daniel Marquardt, Boehringer Ingelheim, Germany
Dr Ann McGee, McGee Pharma International,Ireland

Zielsetzung

This 2-day Master Class brings together well-experienced experts to discuss the latest expectations and requirements for Quality Metrics and KPIs and how they are linked to Continual Quality Improvement (CQI) and Business Continuity. This will support you turning your company’s quality excellence goals into reality.

Hintergrund

To remain ‘regulatory compliant’ and to ensure the continuity of product supply in a cost-effective way, systems and processes must be evaluated and the respective processes simplified and controlled. Important tools in this context are accurate Quality Metrics, the right Key Performance Indicators (KPIs) and Continual Quality Improvement.

Quality Metrics in itself are not new, though. They have already been used in pharmaceutical industry for years – even though mainly internally to measure operational performance. But quality can be measured on different levels and for many processes. Done in the right way, Quality Metrics can enable companies to reach a high quality performance. They will benefit from a continuous improvement in both operational performance and GMP compliance. And both are important for the continuity of business and product supply.

Now, the U.S. FDA has set up an initiative to use Quality Metrics for risk based inspections and published a draft Guidance for Industry in July 2015. In Europe agencies also use Quality Metrics. They are aiming to help regulators to separate manufacturing sites with poor standards from those continuously working on quality improvement.
In the end Quality Metrics will enable companies and regulators to benefit from a continuous investment in GMP to guarantee a high quality performance and the continuity of quality product supply.

Zielgruppe

Managers and Executives from pharmaceutical Quality Assurance and Quality Management but also Business Executives and Production Managers and those involved managing the continuity of product supply.

Programm

Quality Metrics and beyond

FDA’s Quality Metrics Initiative
Expectations in the EU
Quality Culture as the basis for quality improvements
How to involve the management in Quality Metrics
Set up of a practical review system
Follow up actions on management reviews

Integration of Quality Metrics Systems and KPIs in Continuous Improvement and Business Continuity

Understanding critical processes & where quality risks lie/ process mapping
Defining the right KPIs
Meaningful metrics (and the pitfalls)
The role of Quality Impact Assessment & effectiveness checks
The link to Opportunities for Improvement (OFIs), Continuous Quality Improvements (CQIs) and Business Continuity

Techniques to evaluate Quality Performance

Process Analysis
Root Cause Analysis
Cause-and-Effect Diagrams
Risk Assessment
Quality Cockpit
KPIs
Tracking & Trending

Assignment of Metrics and Correlation with Process Controls

The importance of proper use and relevance of lagging and leading KPIs in correlation with process controls.
The set up and implementation of a risk based data evaluation methods for continual improvement and the Management Review

Psychological Aspects of Continuous Improvement

What do the numbers tell us?
Business culture
Empowerment of people

Change Management as the Key

How to shift individuals, teams, and organisations from a current state to a desired future state
How to organise processes to empower employees to accept and embrace changes in their current business environment
8 Steps of Change (Kotter)

Wrap-up: What the Future will bring

True understanding of the quality risks specific to our businesses
A shift to pro-active QRM from reactive risk assessment
Integration of QRM and change management
Moving away from the functional silo mentality
Process and QMS improvement in the interest of patient care
Meaningful performance evaluation criteria and metrics

Case Study: Quality Metrics as a Key Driver for CQI

Why did we implement Metrics?
How did we do it?
What was the outcome?
Lessons learned
How to apply Quality Metrics as a Key Driver for CQI

Parallel sessions (2 out of 3)

1. Managing Data: The Bridge from Quality Metrics to CQI
Defining the right KPIs and Meaningful metrics (work on examples)
What to learn from the data

2. The new FDA Guideline on Quality Metrics – what is it all about?
Overview about the current status
Key areas and data to be submitted
How industry can prepare
The link to ICH Q12: Quality Metrics as part of Product Lifecycle Management

3. Analysis Tools for assessing and optimising Process Flows
How to choose and use the correct tools

You will be able to attend 2 of these sessions. Please choose the ones you like to attend when you register for the course.

Zurück

Quality Metrics to foster Continual Quality ImprovementIm Auftrag der European Compliance Academy